Cambridge Enterprise Ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Semarion secures £2.9m in funding led by Parkwalk to accelerate cell-based drug discovery
Semarion develops cell assay technology that enables adherent cell models to be handled as assay-ready, barcoded reagents. Its platform is used by pharmaceutical and life sciences organisations to improve flexibility, scalability and data generation in drug discovery workflows.
xWatts lands a £1.6m seed round led by Cambridge Enterprise Ventures to decarbonise complex real estate
xWatts builds an energy management platform that connects to building systems and optimises performance in real time. It helps complex estates reduce energy consumption and carbon emissions through automated control.
Sparxell raises £3.7m in funding led by SWEN Capital Partners to replace toxic chemicals with plant-based colour technology
Sparxell develops plant-based structural colour materials as alternatives to synthetic dyes and pigments. It manufactures cellulose-based colourants for use in textiles, cosmetics and other consumer products.
Cambridge Photon Technology raises £1.6m in funding led by Cambridge Enterprise to turn unused light into usable power
Cambridge Photon Technology builds photon-multiplier materials that increase the efficiency of standard silicon solar panels by converting wasted high energy light into usable power without changing existing manufacturing processes.
NoBACZ Healthcare raises £4.8m led by The Yield Lab to expand liquid bandage technology for livestock and horses
NoBACZ Healthcare develops antibiotic-free liquid bandage technology for livestock and horses, creating protective wound coatings that reduce infection risk in agricultural environments.
Trismik secures £2.2m pre-seed led by Twin Path Ventures to launch tools for designing and analysing LLM experiments
Trismik provides tools for evaluating large language models using adaptive testing, helping AI teams measure capability, safety and reasoning more accurately while reducing the cost and time of traditional benchmarking.
Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
More venture news
- 16 Apr 2026
OpenmooveOpenmoove lands £700k in funding led by Development Bank of Wales to streamline property transaction workflows
EquityProperty - 15 Apr 2026
The Little LoopThe Little Loop secures £750k in funding from The FSE Group for B2B2C clothing trade-in and resale platform
EquityCommerce - 15 Apr 2026
AscensionAscension secures £1.7m in funding from UKI2S and Innovate UK to tap geothermal critical mineral reserves
EquityIndustrial
